Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancer
Gürkan Mollaoglu(New York University), Trudy G. Oliver(University of Utah), Jeffery M. Vahrenkamp(University of Utah), Kristofer C. Berrett(University of Utah), Melissa H. Cessna(Intermountain Healthcare), Soledad A. Camolotto(University of Utah), Eric L. Snyder(University of Utah), Chris Stubben(Huntsman Cancer Institute), Jason Gertz(University of Utah), Mohamed E. Salama(Mayo Clinic in Arizona), Timothy L. Mosbruger(Johns Hopkins University), Sangmin Jeong(University of Utah), Kevin B. Jones(Huntsman Cancer Institute), Sarah J. Wait(University of Utah), Alex Jones(University of Utah), Rahul Singh Arya(University of Utah), Anandaroop Mukhopadhyay(University of Utah), Benjamin L. Witt(University of Utah), Thomas E. Lane(University of Utah), Arjun Bhutkar(Massachusetts Institute of Technology), Christopher J. Conley(Huntsman Cancer Institute)
Cited by 0
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|607
miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
|Cancer Research|2012|361
A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma
|Nature|2017|348
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
|Nature Biotechnology|2017|340
Cellular immune selection with hepatitis C virus persistence in humans
|The Journal of Experimental Medicine|2005|304